Startups
Fever syndromes account for over 1 billion episodes annually and are one of the most common reasons to seek care worldwide. For the nearly 3 billion people who live in the equatorial belt a high fever can signal the onset of potentially deadly infectious diseases.
E25Bio Inc. is a Tough Tech company backed by Venture Capital (Khosla Ventures, MIT The Engine) and NIH/Gates Foundation developing Rapid Diagnostic Tests for fever infectious diseases. Existing solutions rely heavily on centralized laboratory equipment and trained staff, cold chain for specimen transport, and hub-and-spoke reporting mechanisms for data. Our innovations aim to provide people with a much simpler alternative: to identify infectious diseases in time to avoid serious complications and death. Through early and accurate screening, we can help equip the right patient with the right treatment at the right time.
E25Bio Inc. is a Tough Tech company backed by Venture Capital (Khosla Ventures, MIT The Engine) and NIH/Gates Foundation developing Rapid Diagnostic Tests for fever infectious diseases. Existing solutions rely heavily on centralized laboratory equipment and trained staff, cold chain for specimen transport, and hub-and-spoke reporting mechanisms for data. Our innovations aim to provide people with a much simpler alternative: to identify infectious diseases in time to avoid serious complications and death. Through early and accurate screening, we can help equip the right patient with the right treatment at the right time.
Overview
Location
United States, Massachusetts, Cambridge
Employees
11-50
Total raised
$4.3M
Founded date
2018
Investors 1
| Date | Name | Website |
| Sign up to see | Sign up to see | Sign up to see |
Funding Rounds 2
| Date | Series | Amount | Investors |
| Sign up to see | Sign up to see | Sign up to see | Sign up to see |
| Sep 3, 2019 | Seed round | $2.3M |
Mentions in press and media 7
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Mar 18, 2020 | E25Bio Closes $2M in Financing to Diagnose Coronavirus | E25Bio, a Cambridge, Mass.-based developer of rapid diagnostic tests, raised $2m in financing. Khosla Ventures made the investment. The new funding will go towards research and development, clinical studies, and scaling the company’s launch... |
| Mar 18, 2020 | E25Bio Lands $2M Seed Funding | CAMBRIDGE, MA, E25Bio Raises $2M From Khosla Ventures. >> Click here for more funding data on E25Bio >> To export E25Bio funding data to PDF and Excel, click here E25Bio, innovators of rapid diagnostic tests, announced to... |
| Mar 18, 2020 | E25Bio Raises $2M From Khosla Ventures To Create Rapid COVID-19 Diagnostic Test | 35 Shares Email Facebook Twitter LinkedIn E25Bio, a developer of rapid diagnostic tests for dangerous infectious diseases, announced this morning that it has raised a $2 million financing from storied VC firm Khosla Ventures. Subscribe to t... |
| Sep 3, 2019 | Diagnostic Technology Company E25Bio Raises $2.3 Million | E25Bio, a company that enables faster and more accurate healthcare access through its point-of-care diagnostic technology, announced it raised $2.3 million E25Bio — a company that enables faster and more accurate healthcare access through i... |
| Aug 26, 2019 | E25Bio Raises $2.3 Million | CAMBRIDGE, Mass.--(BUSINESS WIRE)--E25Bio, enabling faster and more accurate healthcare access through its rapid, point-of-care, diagnostic technology, today announced it has raised $2.3 million in seed funding. Led by The Engine, which was... |
| Aug 26, 2019 | E25Bio Raises $2.3M in Seed Funding | E25Bio, a Cambridge, Mass.-based provider of rapid, point-of-care, diagnostic technology, raised $2.3m in seed funding. The round was led by The Engine, with participation from Alumni Ventures Group and angel investor Alejandro Chavez. Foun... |
Reviews 0
FAQ about E25Bio
When was E25Bio founded?
E25Bio was founded in 2018.
How much funding has E25Bio raised?
E25Bio has raised $4.3M in total across 2 funding rounds.
What funding rounds has E25Bio raised?
Parsers VC lists 2 funding rounds of E25Bio, among them a seed round of $2.3M on Sep 3, 2019.
What has the press written about E25Bio?
Parsers VC has collected 7 articles mentioning E25Bio, among them “E25Bio Closes $2M in Financing to Diagnose Coronavirus” (Mar 18, 2020) and “E25Bio Lands $2M Seed Funding” (Mar 18, 2020).
Is E25Bio still active?
Yes, E25Bio is active; its latest activity on Parsers VC dates from Sep 15, 2020.